z-logo
open-access-imgOpen Access
Quality-of-Life Outcomes Among Ovarian Cancer Patients Treated With Veliparib
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723524.32591.92
Subject(s) - veliparib , medicine , placebo , ovarian cancer , quality of life (healthcare) , parp inhibitor , carboplatin , cancer , oncology , chemotherapy , pathology , alternative medicine , poly adp ribose polymerase , biochemistry , nursing , polymerase , chemistry , cisplatin , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here